DR. FREDERICK STANLEY WREFORD, M.D.
Medical Practice at Professional Dr, Cadillac, MI
License number
Michigan 4301407392
Category
Medical Practice
Type
Anatomic Pathology & Clinical Pathology
Address
Address
8865 Professional Dr SUITE 3, Cadillac, MI 49601
Phone
(231) 468-2346
(231) 468-2349 (Fax)
(231) 468-2349 (Fax)
Professional information
Frederick Stanley Wreford, Cadillac MI
Specialties:
Pathology, Anatomic Pathology & Clinical Pathology, Clinical Pathology
Work:
Mercy Hospital Cadillac
8865 Professional Dr, Cadillac, MI 49601
8865 Professional Dr, Cadillac, MI 49601
Education:
American University of the Caribbean (1986)
Dr. Frederick S Wreford, Cadillac MI - MD (Doctor of Medicine)
Specialties:
Anatomic & Clinical Pathology
Address:
Advance Pathology Services PC
8865 Professional Dr STE C, Cadillac 49601
(231) 468-2346 (Phone)
8865 Professional Dr STE C, Cadillac 49601
(231) 468-2346 (Phone)
Certifications:
Anatomic & Clinical Pathology, 1992
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Advance Pathology Services PC
8865 Professional Dr STE C, Cadillac 49601
Mercy Hospital - Cadillac
400 Hobart St, Cadillac 49601
8865 Professional Dr STE C, Cadillac 49601
Mercy Hospital - Cadillac
400 Hobart St, Cadillac 49601
Education:
Medical School
American University of The Caribbean / School of Medicine
Mt Carmel Mercy Hosp
Grand Rapids Area Med Educ Coun
Cleveland Clinic Foundation
American University of The Caribbean / School of Medicine
Mt Carmel Mercy Hosp
Grand Rapids Area Med Educ Coun
Cleveland Clinic Foundation
Enhanced Detection Of Non-Somatic Circulating Nucleic Acids
US Patent:
2013028, Oct 24, 2013
Filed:
Sep 17, 2012
Appl. No.:
13/621414
Inventors:
Frederick S. Wreford - Cadillac MI, US
International Classification:
G01N 21/59, C12M 1/40
US Classification:
435 611, 435 612, 4352872
Abstract:
Methods, equipment and software for the detection of abnormal nucleic acid or fetal nucleic acid sequences circulating in the subject's blood or other body fluids. A scan of a subject's circulating nucleic acid (CNA) is compared to the CNA Data On Normal Healthy Population or to a scan of the subject's own Somatic Nucleic Acid (SNA). Abnormal peaks are identified by subtracting out the “normal” or somatic peaks. The resultant anomalous peaks are compared to anomalous CNA data to identify the abnormalities, or the anomalous peaks of the subject's CNA are isolated, amplified, and sequenced or probed to determine the nature of the anomaly.